0000000000465058

AUTHOR

Juan Sanchis Forés

showing 6 related works from this author

Cocaine-induced coronary thrombosis and acute myocardial infarction

2004

A 26-year-old man was admitted to our hemodynamic laboratory because of an anterior AMI and post myocardial infarction angina. He is an active smoker (10 cigarettes/day) and consumes inhaled cocaine during weekends (the last consumption of cocaine was 1 week ago). No others risk factors were recorded. Initial electrocardiogram shows sinus rhythm and anterior QS complex (V1–V3) with anterolateral ST segment elevation (V1–V5, D1 and aVL). Creatine-kinase isoenzyme MB and Troponin I were elevated at arrival. Upon admission, the patient was normotensive but with signs of pulmonary congestion. Ventriculography showed anterolateral and apical hypokinesia with an ejection fraction of 21%. Coronari…

medicine.medical_specialtyEjection fractionbusiness.industryElectrocardiography in myocardial infarctionAnterior Descending Coronary Arterymedicine.diseaseThrombosisAnginaCoronary thrombosisRight coronary arterymedicine.arteryInternal medicinemedicineCardiologyMyocardial infarctionCardiology and Cardiovascular MedicinebusinessInternational Journal of Cardiology
researchProduct

Alteration of Ventricular Fibrillation by Flecainide, Verapamil, and Sotalol

2000

Background—The purpose of this study was to determine whether the myocardial electrophysiological properties are useful for predicting changes in the ventricular fibrillatory pattern. Methods and Results—Thirty-two Langendorff-perfused rabbit hearts were used to record ventricular fibrillatory activity with an epicardial multiple electrode. Under control conditions and after flecainide, verapamil, or d,l-sotalol, the dominant frequency (FrD), type of activation maps, conduction velocity, functional refractory period, and wavelength (WL) of excitation were determined during ventricular fibrillation (VF). Flecainide (1.9±0.3 versus 2.4±0.6 cm, P<0.05) and sotalol (2.1±0.3 versus 2.5±0.5 cm, P…

ElectrophysiologyVentricular fibrillation ; Mapping ; Antiarrhythmic agents ; ElectrophysiologyMapping:CIENCIAS MÉDICAS ::Medicina interna [UNESCO]UNESCO::CIENCIAS MÉDICASAntiarrhythmic agentsVentricular fibrillation:CIENCIAS MÉDICAS [UNESCO]UNESCO::CIENCIAS MÉDICAS ::Medicina interna
researchProduct

Trefoil factor-3 and galectin-4 as new candidates for prognostic biomarkers in ST-segment elevation myocardial infarction

2020

medicine.medical_specialtybusiness.industryTrefoil factor 3Galectin 4Galectin 4Myocardial InfarctionElevationGeneral MedicinePrognosismedicine.diseaseElectrocardiographyTreatment OutcomeInternal medicineCardiologyHumansST Elevation Myocardial InfarctionMedicineST segmentMyocardial infarctionTrefoil Factor-3businessBiomarkersRevista Española de Cardiología (English Edition)
researchProduct

Inhomogeneidad de respuesta del nodo auriculo-ventricular

1987

Biology PhysiologyUNESCO::CIENCIAS MÉDICAS:CIENCIAS MÉDICAS [UNESCO]
researchProduct

Amplitud de distribución eritrocitaria y riesgo de mortalidad en pacientes con insuficiencia cardiaca aguda

2013

Resumen Fundamento y objetivo El ancho de distribucion eritrocitaria (ADE) es una medida cuantitativa de la variabilidad del tamano de los eritrocitos circulantes utilizada clasicamente para el diagnostico diferencial de las anemias. En los ultimos anos, se ha sugerido que el ADE podria ser un marcador pronostico util en pacientes con insuficiencia cardiaca cronica. Sin embargo, es escasa la evidencia que respalda su papel en poblacion no seleccionada con insuficiencia cardiaca aguda (ICA), de manera independiente a los factores de riesgo establecidos. El objetivo del estudio fue establecer la asociacion entre el ADE y la mortalidad a largo plazo en pacientes ingresados por ICA. Pacientes y…

Gynecologymedicine.medical_specialtybusiness.industryErythrocyte indicesmedicineFollow up studiesGeneral MedicineUltrasonographybusinessMedicina Clínica
researchProduct

Factor trefoil-3 y galectina-4 como nuevos candidatos para biomarcadores pronósticos en infarto de miocardio con elevación del segmento ST

2020

business.industryMedicineCardiology and Cardiovascular MedicinebusinessHumanitiesRevista Española de Cardiología
researchProduct